NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr | ₹9.80 Cr | ₹-0.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-68 Cr |
Mar2023 | ₹9.00 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹9.80 Cr |
Mar2020 | ₹-0.50 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-68 Cr | Negative | |
Mar2023 | ₹9.00 Cr | -88.16 | |
Mar2022 | ₹76 Cr | 675.51 | |
Mar2021 | ₹9.80 Cr | Positive | |
Mar2020 | ₹-0.50 Cr | - |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹18,535.1 Cr | 6% | 17.4% | -19.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 6% |
17.4% |
-19.4% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses